MYOV - Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q4 2021 Results - Earnings Call Transcript
Myovant Sciences Ltd. (MYOV) Q4 2021 Earnings Conference Call May 10, 2022 08:30 AM ET Company Participants Uneek Mehra - Chief Financial & Business Officer Dave Marek - Chief Executive Officer Lauren Merendino - Chief Commercial Officer Juan Camilo Arjona - Chief Medical Officer Conference Call Participants Phil Nadeau - Cowen & Company Brian Skorney - Baird Eric Joseph - JPMorgan Roanna Ruiz - SVB Securities Gavin Clark-Gartner - Evercore ISI Presentation Operator Good day, everyone and welcome to Myovant Sciences' Fourth Quarter and Fiscal Year 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Uneek Mehra, Chief Financial & Business Officer at Myovant. Please go ahead. Uneek Mehra Thank you, operator. Good morning and thank you for joining us today to discuss of Myovant's corporate update and review of the financial results of Myovant's fourth fiscal quarter
For further details see:
Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q4 2021 Results - Earnings Call Transcript